IW

Iris Wang

TruMed Investment - Founding Partner

Hong Kong

Investor
VC

Invests in

Stages:

Series B
Series A

Sectors:

Pharmaceuticals
Digital Health
BioTech
Health & Hospital Services
Health IT

Locations:

Hong Kong
  • Min Investment:

    $1,000,000.00
  • Max Investment:

    $75,000,000.00
  • Target Investment:

    $4,000,000.00

Skills

Financial Modeling
Investment Banking
Business Strategy
Capital Markets
Due Diligence
Emerging Markets
Equities
Equity Research
Corporate Finance
Private Equity
Financial Analysis
Strategy
Valuation

Education

  • CB

    Master of Business Administration - MBA

    Columbia Business School

    (2009 - 2011)

  • PU

    Bachelor's degree

    Peking University

Lists including Iris

AT
AS
AT
AH

All Series A Investors

14748 people

Investments

Dingdang Kuaiyao

Private Equity

Total Funding: $220M

EDDA Technology

Private Equity

Total Funding: $150M

YS Biopharma

Series B

Total Funding: $130M

Harbour Biomed

Series C

Total Funding: $100M

Akeso Biopharma

Series D

Total Funding: $150M

Alphamab Oncology

Series A

Total Funding: $160M

Work Experience

TruMed Investment

2021

  • Founding Partner

    2021

O
OrbiMed

2017 - 2021

  • Partner

    2021 - 2021

  • Managing Director

    2019 - 2021

  • Director, Public Equity, Asia

    2017 - 2019

CS
Credit Suisse

2011 - 2017

  • Director

    2011 - 2017

Latest Articles

Medium•Nov. 2018

Why I start writing on Medium?

Data Science
Career Change
Medium blogging
Business Analytics
data science career

All information is sourced from public domain and might be inaccurate.

|

By continuing, you're agreeing to our Terms and Privacy Policy.

|

Learn more About The Network.